Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: A multicenter, placebo-controlled study
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference28 articles.
1. Calcium antagonists for chronic stable angina pectoris;Kirkler;Am J Cardiol,1987
2. Calcium channel blockers: pharmacologic considerations;Braunwald;Am Heart J,1982
3. Effects of Ro 40-5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: comparison with verapamil;Clozel;J Cardiovasc Pharmacol,1989
4. Reduction of exercise-induced regional contractile dysfunction in dogs using a novel calcium channel blocker (Ro 40-5967);Guth;Cardiovasc Drugs Ther,1992
5. In vitro pharmacological profile of Ro 40-5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action;Osterrieder;J Cardiovasc Pharmacol,1989
Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Magnetic Resonance Imaging: Cardiovascular Applications for Clinical Trials;Molecular Imaging;2021
2. Does heart rate influence CMR image quality of the coronary vessel wall?;INT J CARDIOVAS IMAG;2012
3. Aortic stiffness in type-1 diabetes mellitus; beware of hypertension;The International Journal of Cardiovascular Imaging;2011-03-26
4. Reduction of radiation dose using 80 kV tube voltage: a feasible strategy?;The International Journal of Cardiovascular Imaging;2011-03-19
5. 320-row CT: does beat-to-beat motion of the coronary arteries affect image quality?;The International Journal of Cardiovascular Imaging;2011-01-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3